Syndax Pharmaceuticals, Inc. (SNDX): Price and Financial Metrics

Syndax Pharmaceuticals, Inc. (SNDX)

Today's Latest Price: $9.41 USD

1.34 (-12.47%)

Updated Feb 28 12:00am

Add SNDX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SNDX Stock Summary

  • Syndax Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 8.87% of US listed stocks.
  • With a price/sales ratio of 155.22, Syndax Pharmaceuticals Inc has a higher such ratio than 98.28% of stocks in our set.
  • Revenue growth over the past 12 months for Syndax Pharmaceuticals Inc comes in at -34.94%, a number that bests just 5.47% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to SNDX, based on their financial statements, market capitalization, and price volatility, are OTIC, ARDX, RCUS, BCRX, and ATHX.
  • Visit SNDX's SEC page to see the company's official filings. To visit the company's web site, go to
SNDX Daily Price Range
SNDX 52-Week Price Range

SNDX Stock Price Chart More Charts

SNDX Price/Volume Stats

Current price $9.41 52-week high $11.33
Prev. close $10.75 52-week low $4.52
Day low $9.11 Volume 395,600
Day high $10.70 Avg. volume 235,342
50-day MA $9.01 Dividend yield N/A
200-day MA $8.35 Market Cap 255.39M

Syndax Pharmaceuticals, Inc. (SNDX) Company Bio

Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company was founded in 2005 and is based in Waltham, Massachusetts.

SNDX Latest News Stream

Event/Time News Detail
Loading, please wait...

SNDX Latest Social Stream

Loading social stream, please wait...

View Full SNDX Social Stream

SNDX Price Returns

1-mo 41.29%
3-mo 29.08%
6-mo 11.89%
1-year 48.42%
3-year -19.09%
5-year N/A
YTD 7.18%
2019 97.30%
2018 -49.20%
2017 22.18%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6137 seconds.